The Japanese Headache Society and Pfizer are jointly sponsoring a competitive grant program focused on improving the quality of migraine medical care in Japan. This initiative aims to support projects that promote behavioral changes among healthcare professionals, leading to earlier diagnosis and more appropriate treatment for migraine patients.

Focus Areas and Project Types

This Request for Proposal (RFP) specifically targets projects aimed at improving migraine care through behavioral changes and enhanced medical practices. The key areas of interest include:

• Building mechanisms to encourage patients who need treatment to seek medical consultation.

• Facilitating collaboration between expert and non-expert doctors in migraine management.

• Promoting early diagnosis and appropriate treatment through the dissemination of specialized knowledge.

• Assisting children and adolescents with migraine to better understand their condition.

• Educating school physicians, industrial physicians, public health nurses, and pharmacists to improve their knowledge and awareness of migraine.

The program seeks to support projects that translate medical and scientific knowledge into practical application, focusing on building systems and mechanisms to link knowledge with tangible results. Educational programs solely for knowledge acquisition are not eligible.

Funding Details and Project Timeline

Individual projects can request funding up to 1,200,000 JPY. This amount should cover all direct, indirect, and institutional overhead costs, with overhead capped at 28% per Pfizer policy.

The anticipated project duration is up to 2 years, running from December 1, 2025, to November 30, 2027. The funding amount will depend on the expert review panel's evaluation of the proposal and associated costs.

Key dates to remember: The application submission deadline is July 13, 2025. Notification of decisions is expected around October 30, 2025, with projects commencing on December 1, 2025.

Eligibility Criteria

Eligible applicants include medical, dental, nursing, allied health, and pharmacy professional schools, healthcare institutions, professional organizations, government agencies, and other entities with a healthcare improvement mission. Only organizations, not individuals or medical practice groups, are eligible to receive grants.

Collaborations within and between institutions are encouraged, provided all partners have a relevant role and the requesting organization has a key role in the project. The Project Lead/Principal Investigator (PI) must be an employee or contractor of the requesting organization.

The requesting organization must be legally able to receive award funding directly from Pfizer International LLC. For projects offering continuing education credit, the requesting organization must be accredited.

Application Process and Submission

To submit an application, visit www.cybergrants.com/pfizer/loi and click "Start a New LOI." Select "Quality Improvement" for the "Project Type." Then, choose the Competitive Grant Program Name: "2025 IM JP JHS Efforts to Improve Quality of Migraine Medical Care QI" and the Primary Area of Interest: "Pain – Migraine - LOI."

Complete all required sections of the online application and upload your project proposal in the Full Proposal Submission field. Ensure your application is submitted by the deadline: July 13, 2025, at 23:59 Eastern Standard Time.

For questions regarding this RFP, contact Akihiro Kamina at meg.japan@pfizer.com with the subject line "Efforts to Improve Quality of Migraine Medical Care." Applications submitted after the due date will not be reviewed.